Publications 2022

Silwal-Pandit L, Stålberg SM, Henrik J. Johansson, Georgios Mermelekas, Lothe IMB, Skrede ML, Dalsgaard AM, Nebdal D, Helland, Lingjærde OC, Labori KJ, Skålhegg BS, Janne Lehtiö, Kure EH (2022)
Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome
Cancer Res Commun, 2 (6), 434-446
DOI 10.1158/2767-9764.CRC-21-0100, PublikaID 411

Publications 2021

Ojlert AK, Nebdal D, Lund-Iversen M, Ellefsen RA, Brustugun OT, Gran JM, Halvorsen AR, Helland A (2021)
Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy
Acta Oncol., 60 (2), 149-156
DOI 10.1080/0284186X.2020.1854851

Ojlert AK, Nebdal D, Snapkov I, Olsen V, Kidman J, Greiff V, Chee J, Helland A (2021)
Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor
Mol. Oncol., 15 (11), 2958-2968
DOI 10.1002/1878-0261.13082

Publications 2019

Halvorsen AR, Aure MR, Ojlert AK, Brustugun OT, Solberg S, Nebdal D, Helland A (2019)
Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC
Mol. Oncol., 13 (12), 2604-2615
DOI 10.1002/1878-0261.12571

Lindholm EM, Aure MR, Haugen MH, Sahlberg KK, Kristensen VN, Nebdal D, Borresen-Dale AL, Lingjrde OC, Engebraaten O (2019)
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
Mol. Oncol., 13 (10), 2278-2296
DOI 10.1002/1878-0261.12561

Ojlert AK, Halvorsen AR, Nebdal D, Lund-Iversen M, Solberg S, Brustugun OT, Lingjaerde OC, Helland A (2019)
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery
Mol. Oncol., 13 (5), 1166-1179
DOI 10.1002/1878-0261.12475

Tekpli X, Lien T, Rossevold AH, Nebdal D, Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M, Due EU, Svartdal LG, Sveli MAT, Garred O, Frigessi A, Sahlberg KK, Sorlie T, Russnes HG, Naume B, Kristensen VN, Borresen-Dale AL, Schlichting E, Sauer T, Geisler J, Hofvind S, Bathen TF et al. (2019)
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
Nat. Commun., 10, 5499
DOI 10.1038/s41467-019-13329-5

Publications 2018

Kaveh F, Baumbusch LO, Nebdal D, Borresen-Dale AL, Lingjaerde OC, Edvardsen H, Kristensen VN, Solvang HK (2018)
A systematic comparison of copy number alterations in four types of female cancer (vol 16, 913, 2016)
BMC Cancer, 18
DOI 10.1186/s12885-017-3766-7

Rye IH, Trinh A, Saetersdal AB, Nebdal D, Lingjaerde OC, Almendro V, Polyak K, Borresen-Dale AL, Helland A, Markowetz F, Russnes HG (2018)
Intratumor heterogeneity defines treatment-resistant HER2+breast tumors
Mol. Oncol., 12 (11), 1838-1855
DOI 10.1002/1878-0261.12375

Publications 2017

Fleischer T, Tekpli X, Mathelier A, Wang SX, Nebdal D, Dhakal HP, Sahlberg KK, Schlichting E, Borresen-Dale AL, Borgen E, Naume B, Eskeland R, Frigessi A, Tost J, Hurtado A, Kristensen VN, Oslo Breast Canc Res Consortium OS (2017)
DNA methylation at enhancers identifies distinct breast cancer lineages
Nat. Commun., 8, 1379
DOI 10.1038/s41467-017-00510-x

Publications 2016

Kaveh F, Baumbusch LO, Nebdal D, Borresen-Dale AL, Lingjaerde OC, Edvardsen H, Kristensen VN, Solvang HK (2016)
A systematic comparison of copy number alterations in four types of female cancer
BMC Cancer, 16, 913
DOI 10.1186/s12885-016-2899-4

Publications 2014

Halvorsen AR, Helland A, Fleischer T, Haug KM, Alnaes GIG, Nebdal D, Syljuasen RG, Touleimat N, Busato F, Tost J, Saetersdal AB, Borresen-Dale AL, Kristensen V, Edvardsen H (2014)
Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy
Int. J. Cancer, 135 (9), 2085-2095
DOI 10.1002/ijc.28862

Publications 2013

Edvardsen H, Landmark-Hoyvik H, Reinertsen KV, Zhao X, Grenaker-Alnaes GI, Nebdal D, Syvanen AC, Rodningen O, Alsner J, Overgaard J, Borresen-Dale AL, Fossa SD, Kristensen VN (2013)
SNP in TXNRD2 Associated With Radiation-Induced Fibrosis: A Study of Genetic Variation in Reactive Oxygen Species Metabolism and Signaling
Int. J. Radiat. Oncol. Biol. Phys., 86 (4), 791-799
DOI 10.1016/j.ijrobp.2013.02.025

Landmark-Hoyvik H, Dumeaux V, Nebdal D, Lund E, Tost J, Kamatani Y, Renault V, Borresen-Dale AL, Kristensen V, Edvardsen H (2013)
Genome-wide association study in breast cancer survivors reveals SNPs associated with gene expression of genes belonging to MHC class I and II
Genomics, 102 (4), 278-287
DOI 10.1016/j.ygeno.2013.07.006

Publications 2011

Ronneberg JA, Fleischer T, Solvang HK, Nordgard SH, Edvardsen H, Potapenko I, Nebdal D, Daviaud C, Gut I, Bukholm I, Naume B, Borresen-Dale AL, Tost J, Kristensen V (2011)
Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer
Mol. Oncol., 5 (1), 61-76
DOI 10.1016/j.molonc.2010.11.004